Thromboprophylaxis in Pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 45, Issue 2, 2018, Pages 389-402

  Kolettis, Diana ^a   Craigo, Sabrina ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Pregnancy; Prophylaxis; Thromboembolism; Thromboprophylaxis

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; BREAST FEEDING; CESAREAN SECTION; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HOSPITAL ADMISSION; HUMAN; IMMOBILIZATION; MATERNAL MORBIDITY; MATERNAL MORTALITY; OBESITY; OUTPATIENT CARE; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; CHEMOPROPHYLAXIS; FEMALE; LUNG EMBOLISM; PREGNANCY COMPLICATION; VEIN THROMBOSIS;

CESAREAN SECTION; CHEMOPREVENTION; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 85046632253     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2018.01.007     Document Type: Review

References (42)

1. Ginsberg, J.S., Bates, S.M., Management of venous thromboembolism during pregnancy. J Thromb Haemost 1 (2003), 1435–1442.
2. Heit, J.A., Kobbervig, C.E., James, A.H., et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143:10 (2005), 697–706.
3. James, A.H., Jamison, M.G., Brancazio, L.R., Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194 (2006), 1311–1315.
4. Simpson, E.L., Lawrenson, R.A., Nightingale, A.L., et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. Br J Obstet Gynaecol 108:1 (2001), 56–60.
5. Bain, E., Wilson, A., Tooher, R., et al. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev(2), 2014 CD001689.
6. The American Congress of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol 118 (2011), 718–729.
7. Thrombosis and embolism during pregnancy and the puerperium, reducing the risk. Green-top guideline no. 37a. 2015, The Royal College of Obstetricians and Gynaecologists (RCOG), London.
8. Morris, R., Evidence- based compression: prevention of stasis and deep vein thrombosis. Ann Surg 239:2 (2004), 162–171.
9. Amaragiri, S.V., Lees, T.A., Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev(3), 2000 CD001484.
10. Muñoz, E.M., Linhardt, R.J., Heparin-binding domains in vascular biology. Arterioscler Thromb Vasc Biol 24:9 (2004), 1549–1557.
11. Clark, N.P., Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy. Pharmacotherapy 30:4 (2010), 369–374.
12. Wesseling, J., van Driel, D., Heymans, H.S., et al. Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost 85 (2001), 609–613.
13. Lee, H.C., Cho, S.Y., Lee, H.J., et al. Warfarin-associated fetal intracranial hemorrhage: a case report. J Korean Med Sci 18 (2003), 764–767.
14. Pati, S., Helmbrecht, G.D., Congenital schizencephaly associated with in utero warfarin exposure. Reprod Toxicol 8 (1994), 115–120.
15. Marik, P.E., Plante, L.A., Venous thromboembolic disease and pregnancy. N Engl J Med 359 (2008), 2025–2033.
16. Forestier, F., Daffos, F., Rainaut, M., et al. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemost, 57(2), 1987, 234.
17. Ginsberg, J.S., Kowalchuk, G., Hirsh, J., et al. Heparin therapy during pregnancy. Risks to the fetus and mother. Arch Intern Med, 149(10), 1989, 2233.
18. Greer, I.A., Nelson-Piercy, C., Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood, 106(2), 2005, 401.
19. Weitz, J.I., Low-molecular-weight heparins. N Engl J Med, 337(10), 1997, 688.
20. Blann, A.D., Landray, M.J., Lip, G.Y.H., An overview of antithrombotic therapy. BMJ 325:7367 (2002), 762–765.
21. Iturbe-Alessio, I., Fonseca, M.C., Mutchinik, O., et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med, 315(22), 1986, 1390.
22. Knol, H.M., Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost 8:8 (2010), 1876–1879.
23. Agnelli, G., Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:8 (2013), 699–708.
24. Reilly, C.R., Successful gestation and delivery using clopidogrel for secondary stroke prophylaxis; a case report and literature review. Arch Gynecol Obstet 290:3 (2014), 591–594.
25. Horlocker, T.T., Wedel, D.J., Rowlingson, J.C., et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med 35:1 (2010), 64–101.
26. The American Congress of Obstetricians and Gynecologists (ACOG) Committee of Practice Bulletins: obstetrics practice bulletin #138 inherited thrombophilias in pregnancy. Obstet Gynecol 122:3 (2013), 706–717.
27. Dargaud, Y., Rugeri, L., Vergnes, M.C., et al. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicenter prospective study. Br J Haematol 145 (2009), 825–835.
28. Bates, S.M., Greer, I.A., Middeldorp, S., et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(2 Suppl), 2012, e691S.
29. Roeters van Lennep, J.E., Meijer, E., Klumper, F.J., et al. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?. J Thromb Haemost, 9(3), 2011, 473.
30. Kamel, H., Navi, B.B., Sriram, N., et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 370 (2014), 1307–1315.
31. Alikhan, R., Cohen, A.T., Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev(3), 2009 CD003747.
32. Sultan, A., West, J., Tata, L.J., et al. Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England. BMJ, 347, 2013, f6099.
33. Sibai, B.M., Rouse, D.J., Pharmacologic thromboprophylaxis in obstetrics: broader use demands better data. Obstet Gynecol, 128, 2016, 681.
34. Clark, S.L., Christmas, J.T., Frye, D.R., et al. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol, 211, 2014, 32.e1-9.
35. Centers for Disease Control and Prevention (CDC). Defining adult overweight and obesity. Available at: www.cdc.gov/obesity/adult/defining.html. Accessed November 25, 2017.
36. Morgan, E.S., Wilson, E., Watkins, T., et al. Maternal obesity and venous thromboembolism. Int J Obstet Anesth 21 (2012), 253–263.
37. Overcash, R.T., Somers, A.T., LaCoursiere, D.Y., Enoxaparin dosing after cesarean delivery in morbidly obese women. Obstet Gynecol 125 (2015), 1371–1377.
38. Ettema, H.B., Kollen, B.J., Verheyen, C.P.M., et al. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost 6 (2008), 1093–1098.
39. Grobman, W.A., Gilbert, S.A., Iams, J.D., et al. Activity restriction among women with a short cervix. Obstet Gynecol 121:6 (2013), 1181–1186.
40. da Silva Lopes, K., Takemoto, Y., Ota, E., et al. Bed rest with and without hospitalization in multiple pregnancy for improving perinatal outcome. Cochrane Database Syst Rev(3), 2017 CD012031.
41. MCarty-Singleton, S., Scissione, A.C., Maternal activity restriction in pregnancy and the prevention of preterm birth: an evidence-based review. Clin Obstet Gynecol 57:3 (2014), 616–627.
42. Richter, C., Sitzmann, J., Lang, P., et al. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol 52:6 (2001), 708–710.